Hernia Mesh Devices Market
Get a free sample of this report
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Request Sectional Data
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
The global hernia mesh devices market generated notable revenues in 2024 and is estimated to grow at a modest CAGR during 2025-2034, due to the increased prevalence of hernias, the aging population, and the adoption of minimally invasive surgical procedures. The FDA indicated that an estimated 800,000 inguinal hernias were repaired annually in the United States on average. Hernias, particularly inguinal hernias, have a high frequency around the world in both developed and developing places (usually requiring surgical repair). Surgeons prefer hernia mesh devices for surgical repairs because they strengthen the repaired/injured area and put the recurrence odds at lower rates than simple suture repairs.
The evolving designs of mesh and the historical evolution of biocompatible materials have improved the safety of these implants and made them more appealing to surgeons and patients for overall good long-term outcomes and will reduce complications. The evolution of laparoscopic and robotic-assisted surgical protocols has propelled the popularity of the use of mesh implants because it reduces recovery times and complications associated with any surgical procedure. Global population aging and demand for effective methods of surgical repair will provide steady growth opportunities for the hernia mesh devices market.
The hernia mesh devices industry is anticipated to grow steadily, because of various clinical, demographic, and technological factors contributing to the demand for mesh devices. One of the main factors driving this growth is the increasing incidence of hernias around the world, especially with inguinal, umbilical, and incisional hernias. The use of advanced biomaterials, including composite (synthetic and biological) and biologic (human and porcine) mesh, which have the potential for better integration and healing than traditional mesh and reduced incidence of complications, will also drive demand in the market.
However, the hernia mesh devices market does have challenges. Complications associated with mesh implants including infection, erosion, and migration lead to product recalls and lawsuits, which can diminish confidence from patients and physicians regarding the safety of certain hernia mesh devices. Further, expensive advanced mesh materials and surgical techniques can reduce access in low-income areas.
There are a few key trends affecting the hernia mesh devices industry, and these trends that have a positive effect include increased use of biologic meshes, more procedures being performed using robotic-assisted hernia repairs, and growing preference for composite materials, which offer the best of strength versus bio-compatibility. Biologic meshes, derived from human or animal tissue, are being increasingly utilized in more complicated or infected hernia repairs when the risk of using synthetics would be higher than the potential benefits.
These materials help to mitigate the chance of immune response or any other complication through a lower incidence of integrating with the patient tissue. In addition, there is a rising trend in hernia repair that includes the use of robotic-assisted surgery. Robotic-assisted surgery has the potential to help surgeons improve surgical outcomes because they can perform the procedure with more precision through the standardization of motions, which also mitigates dealing with fatigue that comes with carrying out long and complex tasks, especially when careful manipulation of the tissue is required.
The biologic mesh segment in the hernia mesh devices industry held sizeable growth in 2024 as demand grows for non-synthetic, biocompatible options in complex or contaminated surgical situations. Biologic meshes are either human or animal tissue that has been decellularized, such as porcine dermis or bovine pericardium and are meant to facilitate the regeneration of human tissue and minimize the potential for chronic inflammatory response or immune rejection of implanted mesh.
As such, these biologic meshes are ideal for patients with higher risk of infection, or hernia repair in patients with poor tissue quality. Biologic mesh is typically more expensive than synthetic options, but in many surgical settings, the good clinical outcomes seen with biologic mesh often warranted the increased costs when using biologic mesh in high-risk procedures. In addition, surgeons will choose biologic mesh when previous attempts to use synthetic mesh have failed, or when the use of synthetic mesh is contraindicated for an individual.
The inguinal hernia mesh segment in the hernia mesh devices market will generate notable CAGR through 2034 as demand grows for non-synthetic, biocompatible options in complex or contaminated surgical situations. Biologic meshes are either human or animal tissue that has been decellularized, such as porcine dermis or bovine pericardium and are meant to facilitate the regeneration of human tissue and minimize the potential for chronic inflammatory response or immune rejection of implanted mesh.
As such, these biologic meshes are ideal for patients with higher risk of infection, or hernia repair in patients with poor tissue quality. Biologic mesh is typically more expensive than synthetic options, but in many surgical settings, the good clinical outcomes seen with biologic mesh often warranted the increased costs when using biologic mesh in high-risk procedures. In addition, surgeons will choose biologic mesh when previous attempts to use synthetic mesh have failed, or when the use of synthetic mesh is contraindicated for an individual.
North America hernia mesh devices market will continue to grow significantly through 2034. There is significant population growth attributed to the high prevalence of hernia cases and the North America region's highly sophisticated healthcare infrastructure base with a propensity for the adoption and integration of new surgical technologies. US-based hospitals perform approximately 1 million hernia repairs yearly and utilize mesh implants predominantly as the mesh implant has shown benefits of reduced recurrence.
The key enablers for the North America region in terms of addressing the hernia repair advanced mesh marketplace include: the availability of skilled operating, trained surgical teams, reimbursement/payment paths allowable, and North American medical device developer and manufacturing businesses nearby.
Leading players in the hernia mesh devices industry include:
To position themselves more effectively in the hernia mesh devices market, company executives are relying on a multiparty strategy of innovation, collaboration, and market expansion. The key players in this space are continuing to heavily invest in research and development so that they can launch the next generation of mesh products that will address the common complications associated with existing products, including infection, migration, and chronic pain.
Efforts are focused on products such as new biologic and composite meshes tailored for patient needs. Companies are also making strategic partnerships or consolidating portfolios through acquisition, which enables them to extend their competency in development and geographical reach. Companies are establishing educational and training programs for surgeons to promote sustained adoption of their products.